Autoantibodies in people with newly diagnosed focal epilepsy

Autoantibodies in people with newly diagnosed focal epilepsy

Detalles Bibliográficos
Main Authors:	McGinty, R, Moloney, T, Adcock, J, Kramer, H, Howell, S, Sen, A, Irani, S, Lang, B
Formato:	Conference item
Publicado:	2017

Títulos similares

Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies
por: McGinty, R, et al.
Publicado: (2020)

Real-world prevalence of autoantibodies in epilepsy
por: McGinty, RN, et al.
Publicado: (2020)

The autoantibody mediated epilepsies
por: Irani, S
Publicado: (2019)

Effectiveness and tolerability of perampanel monotherapy in children with newly diagnosed focal epilepsy
por: Fen Zhao, et al.
Publicado: (2023-05-01)

Investigation of neuronal autoantibodies in two different focal epilepsy syndromes.
por: Ekizoglu, E, et al.
Publicado: (2014)

Autoantibodies in epilepsy
por: Lang, B, et al.
Publicado: (2007)

Efficacy and tolerability of eslicarbazepine acetate as monotherapy in patients of newly diagnosed focal epilepsy
por: S. Saxena, et al.
Publicado: (2021-04-01)

Immunophenotyping of autoimmune epilepsy by mass cytometry
por: McGinty, R, et al.
Publicado: (2019)

Altered structural connectome in non-lesional newly diagnosed focal epilepsy: Relation to pharmacoresistance
por: Barbara A.K. Kreilkamp, et al.
Publicado: (2021-01-01)

Potentially pathogenic autoantibodies associated with epilepsy and encephalitis in children and adults.
por: Vincent, A, et al.
Publicado: (2011)

Immunoprofiling of drug-resistant epilepsy with a focus on glutamic acid decarboxylase 65 antibodies
por: McGinty, R
Publicado: (2021)

INVESTIGATION OF AUTO-ANTIBODIES IN PATIENTS DIAGNOSED WITH FOCAL EPILEPSY
por: Ekizoglu, E, et al.
Publicado: (2013)

Epileptiform activity index for assessing oxcarbazepin therapy of newly-diagnosed focal epilepsy in adolescents and adults
por: V. A. Karlov, et al.
Publicado: (2020-11-01)

Pharmacodynamic sodium channel blockers-induced seizure aggravation in patients with newly diagnosed focal epilepsy
por: V. A. Karlov, et al.
Publicado: (2021-08-01)

Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
por: Jia-Qin Yi, et al.
Publicado: (2023-08-01)

Neuroimaging in Newly Diagnosed Epilepsy
por: J Gordon Millichap
Publicado: (2000-09-01)

Autoantibodies as a cause of epilepsy
por: Wroe, S, et al.
Publicado: (2003)

Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
por: Jia-Qin Yi, et al.
Publicado: (2023-09-01)

Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta‐analysis
por: Sanjeev Kharel, et al.
Publicado: (2022-11-01)

Familial Occurrence in Newly Diagnosed Epilepsy
por: J Gordon Millichap
Publicado: (1998-03-01)

Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy.
por: Brenner, T, et al.
Publicado: (2013)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus
por: Dretzke, J, et al.
Publicado: (2004)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus.
por: Dretzke, J, et al.
Publicado: (2004)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus.
por: Dretzke, J, et al.
Publicado: (2004)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus
por: J Dretzke, et al.
Publicado: (2004-06-01)

Tests of Attention in Newly Diagnosed Idiopathic Epilepsy
por: J Gordon Millichap
Publicado: (2002-04-01)

Autoantibody-mediated disorders of the central nervous system.
por: Irani, S, et al.
Publicado: (2008)

Comparison of Lamotrigine and Oxcarbazepine Monotherapy Among Chinese Adult Patients With Newly-Diagnosed Focal-Onset Epilepsy: A Prospective Observational Study
por: Yuncan Chen, et al.
Publicado: (2022-06-01)

The burden of epilepsy and unmet need in people with focal seizures
por: Persefoni Ioannou, et al.
Publicado: (2022-09-01)

Distinct plasma metabolomic signatures differentiate autoimmune encephalitis from drug‐resistant epilepsy
por: Xiong, W, et al.
Publicado: (2024)

Efficacy and safety of perampanel monotherapy in patients with focal‐onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open‐label Study 342 (FREEDOM Study)
por: Takamichi Yamamoto, et al.
Publicado: (2020-06-01)

Anxiety and Depression in Newly Diagnosed Epilepsy: A Matter of Psychological History?
por: Natacha Forthoffer, et al.
Publicado: (2021-10-01)

A role for the preoptic sleep-promoting system in absence epilepsy
por: N. Suntsova, et al.
Publicado: (2009-10-01)

SPECT in Focal Epilepsies
por: Roderick Duncan
Publicado: (2000-01-01)

Dyshormia in focal epilepsy
por: Mauricio F. Villamar, et al.

CXCL13 levels and autoantibody epitope specificities in LGI1-autoantibody syndromes
por: Michael, S, et al.
Publicado: (2019)

Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels.
por: Stagg, C, et al.
Publicado: (2010)

Autoantibody-mediated encephalitis
por: Irani, S
Publicado: (2017)

Effect of clinical features on antiseizure medication doses in patients with newly diagnosed epilepsy
por: Hire Hersi, et al.
Publicado: (2023-08-01)

Cognitive and other neuropsychological profiles in children with newly diagnosed benign rolandic epilepsy
por: Soonhak Kwon, et al.
Publicado: (2012-10-01)